Varicella Vaccine, Live

Good safety of gelatin-free

The first lyophilized Varicella Vaccine, containing no gelatin from animals, invented and produced in China. Getting rid of gelatin from varicella vaccine can significantly decrease the ratio of anaphylaxis incidence. 

Long validity period by good stability

The first approved varicella vaccine with 36 months of validity period in the world.

Adopting BH-2 stabilizer with own IP rights (Chinese patent granted No.: ZL200910138411.6, International patent application No.: PCT/CN2009/001405) greatly enhances the stability of the product and ensures the validity period for 36 months under the storage condition.

Better protection with high titer and immune efficacy

It’s documented that compared with the varicella vaccine of low titer, high titer vaccine can reduce breakthrough cases by nearly 75% after vaccination.

Of all released batches of Varicella Vaccine from BCHT, the titers are not less than 10000 PFU/dose(4.0lgPFU/dose) tested by National Institutes for Food and Drug Control.

Two-dose immunization & Perfect protection

BCHT Varicella Vaccine, Live could be used for basic immunization, booster immunization and two-dose immunization strategies for healthy varicella susceptible people over 12 months old.

More convenient

with ampoule, vial and prefilled syringe of diluent. Adopting BD prefilled syringe, more convenient and comfortable.